Doctors Note Logo

Published on: 9/17/2026

Should I take Linzess on an empty stomach or with breakfast?

Linzess (linaclotide) is designed to be taken on an empty stomach, at least 30 minutes before the first meal of the day, because taking it with food, especially a high-fat breakfast, can lead to looser stools and more frequent diarrhea. Timing matters for both the 72 mcg and 145 mcg constipation doses and the 290 mcg IBS-C dose, and there are additional factors to consider, including what to do about a missed dose, how quickly a bowel movement may occur, and which side effects signal a problem. See below to understand more about correct timing, food interactions, and warning signs that warrant a call to your doctor.

If constipation, bloating, or abdominal pain is still disrupting your day even with treatment, it helps to look at the bigger picture rather than only adjusting when you swallow a pill. A free, instant, online symptom check can help you organize your symptoms, consider possible causes, and decide whether your next step should be a medication review, a diet change, or a visit with a gastroenterologist.

Last reviewed for medical accuracy: 09/17/2026

answer background

Explanation

Should I Take Linzess on an Empty Stomach or with Breakfast?

Linzess (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). One of the most common questions people have is whether to take Linzess on an empty stomach or with food—especially breakfast. This guide breaks down the evidence, official recommendations, and practical tips to help you get the most benefit from your Linzess dose.

What Is Linzess and How Does It Work?

  • Active Ingredient: Linaclotide, a peptide that acts locally in the gut
  • Approved Uses:
    • IBS-C in adults
    • CIC in adults
  • Mechanism of Action:
    • Stimulates secretion of chloride and bicarbonate into the intestinal lumen
    • Increases fluid content and accelerates transit time
    • Reduces visceral pain signals

Understanding this helps explain why timing and stomach conditions matter for optimal absorption and effect.

Official Timing Recommendations

According to the FDA-approved prescribing information for Linzess:

  • Take Linzess once daily, at least 30 minutes before your first meal of the day.
  • Swallow the capsule whole with water—do not crush, chew, or open.
  • If you miss a dose, skip it and take your next dose at the usual time the following day.

Why “30 minutes before”? Linaclotide needs to be in your small intestine before food arrives, so it can reach the local receptors without being delayed or diluted by a meal.

Empty Stomach vs. With Breakfast: What the Research Says

  1. Empty Stomach (Recommended)

    • Ensures rapid delivery to the small intestine
    • Maximizes drug-receptor interaction before food alters gut pH or motility
    • Minimizes risk of reduced effectiveness
  2. With Breakfast (Not Recommended)

    • Food can slow gastric emptying, delaying Linzess release
    • Digestive enzymes and bile acids change the local environment
    • Potential for decreased symptom relief

Clinical trials that led to FDA approval tested Linzess on an empty stomach. Taking it with or immediately after a meal wasn’t studied extensively, so safety and efficacy in that setting aren’t guaranteed.

Benefits of Taking Linzess on an Empty Stomach

  • Consistent Effectiveness: You’re using Linzess exactly as studied in clinical trials.
  • Predictable Relief: More uniform bowel habits when the drug acts predictably.
  • Reduced Variability: Less chance that a heavy or fatty meal will alter drug action.

Practical Tips for Your Linzess Routine

  1. Choose a Fixed Time:
    • Example: 7:00 AM every day, at least 30 minutes before breakfast.
  2. Use Reminders:
    • Set a phone alarm or place the bottle next to your toothbrush.
  3. Water Intake:
    • Take each capsule with a full glass (8 oz) of water.
  4. Meal Planning:
    • Prepare your breakfast the night before so you’re ready to eat 30 minutes after dosing.
  5. Monitor Side Effects:
    • Common: diarrhea, abdominal pain, gas
    • If diarrhea is severe, call your doctor and consider skipping a meal that day until things settle.

What If You Accidentally Take Linzess with Food?

If you forget and take Linzess right before or with breakfast:

  • Effectiveness May Be Lower: Your symptom relief could be reduced.
  • No Major Safety Concern: There’s no evidence of severe harm, but your results may vary.
  • Next Dose: Return to taking it 30 minutes before your next meal.

Managing Common Side Effects

  • Diarrhea:
    • Can occur within hours of first doses
    • Stay hydrated—drink extra fluids
    • If persistent or severe, call your healthcare provider
  • Abdominal Pain or Gas:
    • Often mild and transient
    • Over-the-counter simethicone may help
  • Nausea:
    • Taking on an empty stomach can sometimes trigger mild nausea
    • Try a light snack (e.g., toast) 30 minutes after dosing if needed

Always report bothersome side effects to your doctor.

When to Talk to Your Doctor

While Linzess is generally well tolerated, you should speak to a healthcare professional if you experience:

  • Severe or persistent diarrhea
  • Signs of dehydration (dizziness, dry mouth, decreased urination)
  • Blood in your stool or black, tarry stools
  • Severe abdominal pain or bloating

For non-urgent concerns—like whether you should adjust your timing or dose—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

free, online symptom check, using the doctor approved Ubie Symptom Checker

Key Takeaways

  • Best Practice: Take Linzess once daily on an empty stomach, at least 30 minutes before breakfast.
  • Why It Matters: Food can slow down the drug and reduce its effectiveness.
  • Stick to the Schedule: Consistency helps maintain predictable relief from constipation or IBS-C symptoms.
  • Side Effects: Common but manageable—keep open communication with your doctor.
  • Safety First: For any life-threatening or serious concerns, seek immediate medical attention or call your doctor.

Always remember: this information complements—not replaces—professional medical advice. If you have questions about Linzess dosing or any symptoms that are severe or worrying, please speak to your doctor.

(References)

  • * Mearin F, Rey E, Balboa A. [Functional and motor digestive disorders]. Gastroenterol Hepatol. 2013 Oct;36 Suppl 2:3-14. doi: 10.1016/S0210-5705(13)70048-7. PMID: 24160947.

  • * Corsetti M, Tack J. Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation. United European Gastroenterol J. 2013 Feb;1(1):7-20. doi: 10.1177/2050640612474446. PMID: 24917937; PMCID: PMC4040778.

  • * Mounsey A, Raleigh M, Wilson A. Management of Constipation in Older Adults. Am Fam Physician. 2015 Sep 15;92(6):500-4. PMID: 26371734.

  • * Geijo Martínez F, Sánchez Garrido A, Marcos Prieto H, Piñeiro Pérez C, Prieto Bermejo AB, Álvarez Delgado A, Velasco Guardado A, Rodríguez Pérez A. Long-term results of linaclotide in the treatment of constipation-type irritable bowel syndrome. Rev Esp Enferm Dig. 2018 Jul;110(7):451-457. doi: 10.17235/reed.2018.5268/2017. PMID: 29685047.

  • * Waldman SA, Tenenbaum R, Foehl HC, Winkle P, Griffin P. Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation. Clin Transl Gastroenterol. 2019 Jul;10(7):e00016. doi: 10.14309/ctg.0000000000000016. PMID: 31318728; PMCID: PMC6708669.

  • * Ge P, Ren J, Harrington AM, Grundy L, Castro J, Brierley SM, Hannig G. Linaclotide treatment reduces endometriosis-associated vaginal hyperalgesia and mechanical allodynia through viscerovisceral cross-talk. Pain. 2019 Nov;160(11):2566-2579. doi: 10.1097/j.pain.0000000000001657. PMID: 31335750.

  • * Di Lorenzo C, Khlevner J, Rodriguez-Araujo G, Xie W, Huh SY, Ando M, Hyams JS, Nurko S, Benninga MA, Simon M, Hewson ME, Saps M. Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Gastroenterol Hepatol. 2024 Mar;9(3):238-250. doi: 10.1016/S2468-1253(23)00398-9. Epub 2024 Jan 8. PMID: 38211604.

  • * Kilgore A, Khlevner J. Functional Constipation: Pathophysiology, evaluation, and management. Aliment Pharmacol Ther. 2024 Jul;60 Suppl 1:S20-S29. doi: 10.1111/apt.17852. Epub 2024 Jun 25. PMID: 38925548.

  • * Habek N, Ratko M, Sedmak D, Banovac I, Crljen V, Kordić M, Radmilović M, Škokić S, Tkalčić M, Mažuranić A, Bubalo P, Škavić P, Ljubić S, Rahelić D, Dugandžić A. Brain-derived uroguanylin as a regulator of postprandial brown adipose tissue activation: a potential therapeutic approach for metabolic disorders. Front Pharmacol. 2025;16:1569163. doi: 10.3389/fphar.2025.1569163. Epub 2025 Apr 25. PMID: 40351439; PMCID: PMC12062040.

  • * Fan X, Li Y, Lin X. A pharmacovigilance study of the association between linaclotide/plecanatide and muscle spasms based on food and drug administration adverse event reporting system. Front Pharmacol. 2025;16:1635792. doi: 10.3389/fphar.2025.1635792. Epub 2025 Aug 6. PMID: 40843382; PMCID: PMC12364702.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.